Global Circular RNA Generation Technology Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI07254226

Publication Date:

July 24, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Circular RNA Generation Technology market size is predicted to grow from US$ 522 million in 2025 to US$ 724 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
Circular RNA Generation Technology is a biotechnology aimed at synthesizing Circular RNA (circRNA) in vitro or in vivo through specific biological processes. CircRNA is a novel class of RNA molecules characterized by a covalently closed loop structure, widely existing in eukaryotes and exhibiting diverse biological functions. This technology typically involves the specific design of target gene sequences to form the circular structure required for circRNA. Efficient generation of circRNA can be achieved through precise molecular manipulations such as RNA splicing and circularization. Circular RNA Generation Technology provides an important tool for scientific research, particularly in exploring the functions, mechanisms of action, and applications of circRNA in disease treatment. Additionally, this technology holds promise for bringing new breakthroughs in gene therapy, drug development, and other fields.
United States market for Circular RNA Generation Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Circular RNA Generation Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Circular RNA Generation Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Circular RNA Generation Technology players cover RiboX Therapeutics, Therorna, Curemed, Circode, Orna Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐ircular RNA Generation Technology Industry Forecast鈥� looks at past sales and reviews total world Circular RNA Generation Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected Circular RNA Generation Technology sales for 2025 through 2031. With Circular RNA Generation Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circular RNA Generation Technology industry.
This Insight Report provides a comprehensive analysis of the global Circular RNA Generation Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circular RNA Generation Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Circular RNA Generation Technology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circular RNA Generation Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circular RNA Generation Technology.
This report presents a comprehensive overview, market shares, and growth opportunities of Circular RNA Generation Technology market by product type, application, key players and key regions and countries.
Segmentation by Type:
In Vivo Circular RNA Generation Technology
In Vitro Circular RNA Generation Technology
Segmentation by Application:
Infectious Diseases
Tumors
Rare Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
RiboX Therapeutics
Therorna
Curemed
Circode
Orna Therapeutics
Sail Biomedicines
Geneseed
Chimera Therapeutics
Torque Bio

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circular RNA Generation Technology Market Size (2020-2031)
2.1.2 Circular RNA Generation Technology Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Circular RNA Generation Technology by Country/Region (2020, 2024 & 2031)
2.2 Circular RNA Generation Technology Segment by Type
2.2.1 In Vivo Circular RNA Generation Technology
2.2.2 In Vitro Circular RNA Generation Technology
2.3 Circular RNA Generation Technology Market Size by Type
2.3.1 Circular RNA Generation Technology Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Circular RNA Generation Technology Market Size Market Share by Type (2020-2025)
2.4 Circular RNA Generation Technology Segment by Application
2.4.1 Infectious Diseases
2.4.2 Tumors
2.4.3 Rare Diseases
2.4.4 Others
2.5 Circular RNA Generation Technology Market Size by Application
2.5.1 Circular RNA Generation Technology Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Circular RNA Generation Technology Market Size Market Share by Application (2020-2025)
3 Circular RNA Generation Technology Market Size by Player
3.1 Circular RNA Generation Technology Market Size Market Share by Player
3.1.1 Global Circular RNA Generation Technology Revenue by Player (2020-2025)
3.1.2 Global Circular RNA Generation Technology Revenue Market Share by Player (2020-2025)
3.2 Global Circular RNA Generation Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Circular RNA Generation Technology by Region
4.1 Circular RNA Generation Technology Market Size by Region (2020-2025)
4.2 Global Circular RNA Generation Technology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Circular RNA Generation Technology Market Size Growth (2020-2025)
4.4 APAC Circular RNA Generation Technology Market Size Growth (2020-2025)
4.5 Europe Circular RNA Generation Technology Market Size Growth (2020-2025)
4.6 Middle East & Africa Circular RNA Generation Technology Market Size Growth (2020-2025)
5 Americas
5.1 Americas Circular RNA Generation Technology Market Size by Country (2020-2025)
5.2 Americas Circular RNA Generation Technology Market Size by Type (2020-2025)
5.3 Americas Circular RNA Generation Technology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circular RNA Generation Technology Market Size by Region (2020-2025)
6.2 APAC Circular RNA Generation Technology Market Size by Type (2020-2025)
6.3 APAC Circular RNA Generation Technology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Circular RNA Generation Technology Market Size by Country (2020-2025)
7.2 Europe Circular RNA Generation Technology Market Size by Type (2020-2025)
7.3 Europe Circular RNA Generation Technology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Circular RNA Generation Technology by Region (2020-2025)
8.2 Middle East & Africa Circular RNA Generation Technology Market Size by Type (2020-2025)
8.3 Middle East & Africa Circular RNA Generation Technology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Circular RNA Generation Technology Market Forecast
10.1 Global Circular RNA Generation Technology Forecast by Region (2026-2031)
10.1.1 Global Circular RNA Generation Technology Forecast by Region (2026-2031)
10.1.2 Americas Circular RNA Generation Technology Forecast
10.1.3 APAC Circular RNA Generation Technology Forecast
10.1.4 Europe Circular RNA Generation Technology Forecast
10.1.5 Middle East & Africa Circular RNA Generation Technology Forecast
10.2 Americas Circular RNA Generation Technology Forecast by Country (2026-2031)
10.2.1 United States Market Circular RNA Generation Technology Forecast
10.2.2 Canada Market Circular RNA Generation Technology Forecast
10.2.3 Mexico Market Circular RNA Generation Technology Forecast
10.2.4 Brazil Market Circular RNA Generation Technology Forecast
10.3 APAC Circular RNA Generation Technology Forecast by Region (2026-2031)
10.3.1 China Circular RNA Generation Technology Market Forecast
10.3.2 Japan Market Circular RNA Generation Technology Forecast
10.3.3 Korea Market Circular RNA Generation Technology Forecast
10.3.4 Southeast Asia Market Circular RNA Generation Technology Forecast
10.3.5 India Market Circular RNA Generation Technology Forecast
10.3.6 Australia Market Circular RNA Generation Technology Forecast
10.4 Europe Circular RNA Generation Technology Forecast by Country (2026-2031)
10.4.1 Germany Market Circular RNA Generation Technology Forecast
10.4.2 France Market Circular RNA Generation Technology Forecast
10.4.3 UK Market Circular RNA Generation Technology Forecast
10.4.4 Italy Market Circular RNA Generation Technology Forecast
10.4.5 Russia Market Circular RNA Generation Technology Forecast
10.5 Middle East & Africa Circular RNA Generation Technology Forecast by Region (2026-2031)
10.5.1 Egypt Market Circular RNA Generation Technology Forecast
10.5.2 South Africa Market Circular RNA Generation Technology Forecast
10.5.3 Israel Market Circular RNA Generation Technology Forecast
10.5.4 Turkey Market Circular RNA Generation Technology Forecast
10.6 Global Circular RNA Generation Technology Forecast by Type (2026-2031)
10.7 Global Circular RNA Generation Technology Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Circular RNA Generation Technology Forecast
11 Key Players Analysis
11.1 RiboX Therapeutics
11.1.1 RiboX Therapeutics Company Information
11.1.2 RiboX Therapeutics Circular RNA Generation Technology Product Offered
11.1.3 RiboX Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 RiboX Therapeutics Main Business Overview
11.1.5 RiboX Therapeutics Latest Developments
11.2 Therorna
11.2.1 Therorna Company Information
11.2.2 Therorna Circular RNA Generation Technology Product Offered
11.2.3 Therorna Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Therorna Main Business Overview
11.2.5 Therorna Latest Developments
11.3 Curemed
11.3.1 Curemed Company Information
11.3.2 Curemed Circular RNA Generation Technology Product Offered
11.3.3 Curemed Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Curemed Main Business Overview
11.3.5 Curemed Latest Developments
11.4 Circode
11.4.1 Circode Company Information
11.4.2 Circode Circular RNA Generation Technology Product Offered
11.4.3 Circode Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Circode Main Business Overview
11.4.5 Circode Latest Developments
11.5 Orna Therapeutics
11.5.1 Orna Therapeutics Company Information
11.5.2 Orna Therapeutics Circular RNA Generation Technology Product Offered
11.5.3 Orna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Orna Therapeutics Main Business Overview
11.5.5 Orna Therapeutics Latest Developments
11.6 Sail Biomedicines
11.6.1 Sail Biomedicines Company Information
11.6.2 Sail Biomedicines Circular RNA Generation Technology Product Offered
11.6.3 Sail Biomedicines Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Sail Biomedicines Main Business Overview
11.6.5 Sail Biomedicines Latest Developments
11.7 Geneseed
11.7.1 Geneseed Company Information
11.7.2 Geneseed Circular RNA Generation Technology Product Offered
11.7.3 Geneseed Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Geneseed Main Business Overview
11.7.5 Geneseed Latest Developments
11.8 Chimera Therapeutics
11.8.1 Chimera Therapeutics Company Information
11.8.2 Chimera Therapeutics Circular RNA Generation Technology Product Offered
11.8.3 Chimera Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Chimera Therapeutics Main Business Overview
11.8.5 Chimera Therapeutics Latest Developments
11.9 Torque Bio
11.9.1 Torque Bio Company Information
11.9.2 Torque Bio Circular RNA Generation Technology Product Offered
11.9.3 Torque Bio Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Torque Bio Main Business Overview
11.9.5 Torque Bio Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂